Abstract:IMPORTANCE:Attention-deficit/hyperactivity disorder (ADHD) is conceptualized as a neurodevelopmental disorder that is strongly heritable. However, to our knowledge, no study to date has examined the genetic and environmental influences explaining interindividual differences in the developmental course of ADHD symptoms from childhood to adolescence (ie, systematic decreases or increases with age). The reason ADHD symptoms persist in some children but decline in others is an important concern, with implications for prognosis and interventions.OBJECTIVE:To assess the proportional impact of genes and the environment on interindividual differences in the developmental course of ADHD symptom domains of hyperactivity/impulsivity and inattention between ages 8 and 16 years.DESIGN, SETTING, AND PARTICIPANTS:A prospective sample of 8395 twin pairs from the Twins Early Development Study, recruited from population records of births in England and Wales between January 1, 1994, and December 31, 1996. Data collection at age 8 years took place between November 2002 and November 2004; data collection at age 16 years took place between February 2011 and January 2013.MAIN OUTCOMES AND MEASURES:Both DSM-IV ADHD symptom subscales were rated 4 times by participants' mothers.RESULTS:Estimates from latent growth curve models indicated that the developmental course of hyperactivity/impulsivity symptoms followed a sharp linear decrease (mean score of 6.0 at age 8 years to 2.9 at age 16 years). Interindividual differences in the linear change in hyperactivity/impulsivity were under strong additive genetic influences (81%; 95% CI, 73%-88%). More than half of the genetic variation was specific to the developmental course and not shared with the baseline level of hyperactivity/impulsivity. The linear decrease in inattention symptoms was less pronounced (mean score of 5.8 at age 8 years to 4.9 at age 16 years). Nonadditive genetic influences accounted for a substantial amount of variation in the developmental course of inattention symptoms (54%; 95% CI, 8%-76%), with more than half being specific to the developmental course.CONCLUSIONS AND RELEVANCE:The large genetic influences on the developmental course of ADHD symptoms are mostly specific and independent of those that account for variation in the baseline level of symptoms. Different sets of genes may be associated with the developmental course vs the baseline level of ADHD symptoms and explain why some children remit from ADHD, whereas others persist. Recent longitudinal imaging data indicate that the maintenance or increase in symptoms is underpinned by atypical trajectories of cortical development. This may reflect a specific genetic liability, distinct from that which contributes to baseline ADHD symptoms, and warrants closer follow-up.

Genetic Analysis for Cognitive Flexibility in the Trail-Making Test in Attention Deficit Hyperactivity Disorder Patients from Single Nucleotide Polymorphism, Gene to Pathway Level.

GENETIC STUDY FOR THE NEUROPSYCHOLOGICAL FUNCTION IN ATTENTION DEFICIT HYPERACTIVITY DISORDER

DLGAP1 and NMDA Receptor-Associated Postsynaptic Density Protein Genes Influence Executive Function in Attention Deficit Hyperactivity Disorder.

Mendelian Randomization Analysis of the Brain, Cerebrospinal Fl Uid, and Plasma Proteome Identi Fi Es Potential Drug Targets for Attention De Fi Cit Hyperactivity Disorder

Genetic Variant for Behavioral Regulation Factor of Executive Function and Its Possible Brain Mechanism in Attention Deficit Hyperactivity Disorder.

[Exploration of Common Biological Pathways for Attention Deficit Hyperactivity Disorder and Low Birth Weight].

A High-Density Single-Nucleotide Polymorphism Screen of 23 Candidate Genes in Attention Deficit Hyperactivity Disorder: Suggesting Multiple Susceptibility Genes among Chinese Han Population

New suggestive genetic loci and biological pathways for attention function in adult attention‐deficit/hyperactivity disorder

Genome-wide association study of cognitive flexibility assessed by the Wisconsin Card Sorting Test.

Investigating the shared genetic architecture between attention-deficit/hyperactivity disorder and risk taking behavior: A large-scale genomewide cross-trait analysis

[Association of 14 Polymorphisms in the Five Candidate Genes and Attention Deficit Hyperactivity Disorder].

Novel genetic loci of inhibitory control in ADHD and healthy children and genetic correlations with ADHD

The Implicated Roles of Cell Adhesion Molecule 1 ( CADM1 ) Gene and Altered Prefrontal Neuronal Activity in Attention-Deficit/Hyperactivity Disorder: A "Gene-Brain-Behavior Relationship"?

Polygenic risk of genes involved in the catecholamine and serotonin pathways for ADHD in children

Identification of Risk Genes for Attention-Deficit/Hyperactivity Disorder During Early Human Brain Development

Polygenic Transmission And Complex Neuro Developmental Network For Attention Deficit Hyperactivity Disorder: Genome-Wide Association Study Of Both Common And Rare Variants

Genetic and Environmental Influences on the Developmental Course of Attention-Deficit / Hyperactivity Disorder Symptoms FromChildhood to Adolescence

Genomic Patterns Linked to Gray Matter Alterations Underlying Working Memory Deficits in Adults and Adolescents with Attention-Deficit/hyperactivity Disorder.

Synaptosome-related (SNARE) Genes and Their Interactions Contribute to the Susceptibility and Working Memory of Attention-Deficit/hyperactivity Disorder in Males

A genome-wide association study of attention and executive function in patients with schizophrenia

Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains